Back to Search
Start Over
Inefficient constitutive inhibition of P2X3 receptors by brain natriuretic peptide system contributes to sensitization of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine.
- Source :
-
Molecular pain [Mol Pain] 2016 May 12; Vol. 12. Date of Electronic Publication: 2016 May 12 (Print Publication: 2016). - Publication Year :
- 2016
-
Abstract
- Background: On trigeminal ganglion neurons, pain-sensing P2X3 receptors are constitutively inhibited by brain natriuretic peptide via its natriuretic peptide receptor-A. This inhibition is associated with increased P2X3 serine phosphorylation and receptor redistribution to non-lipid raft membrane compartments. The natriuretic peptide receptor-A antagonist anantin reverses these effects. We studied whether P2X3 inhibition is dysfunctional in a genetic familial hemiplegic migraine type-1 model produced by introduction of the human pathogenic R192Q missense mutation into the mouse CACNA1A gene (knock-in phenotype). This model faithfully replicates several properties of familial hemiplegic migraine type-1, with gain-of-function of CaV2.1 Ca(2+) channels, raised levels of the algogenic peptide calcitonin gene-related peptide, and enhanced activity of P2X3 receptors in trigeminal ganglia.<br />Results: In knock-in neurons, anantin did not affect P2X3 receptor activity, membrane distribution, or serine phosphorylation level, implying ineffective inhibition by the constitutive brain natriuretic peptide/natriuretic peptide receptor-A pathway. However, expression and functional properties of this pathway remained intact together with its ability to downregulate TRPV1 channels. Reversing the familial hemiplegic migraine type-1 phenotype with the CaV2.1-specific antagonist, ω-agatoxin IVA restored P2X3 activity to wild-type level and enabled the potentiating effects of anantin again. After blocking calcitonin gene-related peptide receptors, P2X3 receptors exhibited wild-type properties and were again potentiated by anantin.<br />Conclusions: P2X3 receptors on mouse trigeminal ganglion neurons are subjected to contrasting modulation by inhibitory brain natriuretic peptide and facilitatory calcitonin gene-related peptide that both operate via complex intracellular signaling. In the familial hemiplegic migraine type-1 migraine model, the action of calcitonin gene-related peptide appears to prevail over brain natriuretic peptide, thus suggesting that peripheral inhibition of P2X3 receptors becomes insufficient and contributes to trigeminal pain sensitization.<br /> (© The Author(s) 2016.)
- Subjects :
- Animals
Calcitonin Gene-Related Peptide Receptor Antagonists
Disease Models, Animal
Gene Knock-In Techniques
Mice
Migraine with Aura pathology
Models, Biological
Peptides, Cyclic pharmacology
Phenotype
Purinergic P2X Receptor Antagonists pharmacology
Receptors, Atrial Natriuretic Factor metabolism
Receptors, Calcitonin Gene-Related Peptide metabolism
Sensory Receptor Cells drug effects
Sensory Receptor Cells metabolism
TRPV Cation Channels metabolism
Trigeminal Ganglion drug effects
Trigeminal Ganglion metabolism
omega-Agatoxin IVA pharmacology
Migraine with Aura genetics
Migraine with Aura metabolism
Natriuretic Peptide, Brain metabolism
Receptors, Purinergic P2X3 metabolism
Sensory Receptor Cells pathology
Trigeminal Ganglion pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1744-8069
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Molecular pain
- Publication Type :
- Academic Journal
- Accession number :
- 27175010
- Full Text :
- https://doi.org/10.1177/1744806916646110